Another study of PTCL identified in ALK- ALCLs the highest rate of STAT3 mutations (38%) that may combine with JAK mutations (15%), while some ALK+ ALCLs (13%) presented STAT3 mutation alone [51]. The gene discussed is ALK; the disease is mature T-cell and NK-cell non-Hodgkin lymphoma.